(Q34511505)

2 August 2017

Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial) (English)

1 reference

2 August 2017

1 reference

Lalantha Leelarathna

8

0 references

Mark L. Evans

Mark Evans

14

0 references

Jane Speight

Jane Speight

17

0 references

Simon Heller

Simon Heller

13

0 references

Pratik Choudhary

Pratik Choudhary

3

0 references

author name string

Stuart Little

1

1 reference

2 August 2017

Thomas Chadwick

2

1 reference

2 August 2017

Cath Brennand

4

1 reference

2 August 2017

Julia Stickland

5

1 reference

2 August 2017

Shalleen Barendse

6

1 reference

2 August 2017

Tolulope Olateju

7

1 reference

2 August 2017

Emma Walkinshaw

9

1 reference

2 August 2017

Horng K Tan

10

1 reference

2 August 2017

Sally M Marshall

11

1 reference

2 August 2017

Reena M Thomas

12

1 reference

2 August 2017

David Kerr

15

1 reference

2 August 2017

Daniel Flanagan

16

1 reference

2 August 2017

James Am Shaw

18

1 reference

2 August 2017

13 December 2012

1 reference

2 August 2017

BMC Endocrine Disorders

1 reference

2 August 2017

12

1 reference

2 August 2017

33

1 reference

https://scigraph.springernature.com/pub.10.1186/1472-6823-12-33

2 August 2017

0 references

cites work

Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Diagnosis and classification of diabetes mellitus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Blood glucose awareness training delivered over the internet

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Diabetes prevalence in England, 2001--estimates from an epidemiological model

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Hypoglycemia in diabetes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Symptoms of hypoglycaemia in people with diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

EuroQol--a new facility for the measurement of health-related quality of life

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Unexplained Deaths of Type 1 Diabetic Patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3556156

Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Continuous glucose monitoring and intensive treatment of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Investigations of the functional anatomy of attention using the Stroop test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Development and validation of the insulin treatment satisfaction questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-33

Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes

21 January 2018

1 reference

12 December 2020

An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes

1 reference

12 December 2020

Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes

1 reference

12 December 2020

Development of scales to measure perceived control of diabetes mellitus and diabetes-related health beliefs

1 reference

12 December 2020

Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group

1 reference

12 December 2020

Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia

1 reference

12 December 2020

Reversibility of unawareness of hypoglycemia in patients with insulinomas

1 reference

12 December 2020

Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM

1 reference

12 December 2020

Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6823-12-33

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference